arrow
D

Dongwei Kang

Shandong University
H指数:40
被引数:4,824

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction to “Exploring the HIV-1 Reverse Transcriptase p51/p66 Interface: Structure-Based Design and Optimization of Novel 2; 4; 6-Trisubstituted Pyrimidines as Potent NNRTIs with Improved Resistance Profiles”

“对《探索HIV-1逆转录酶p51/p66界面:基于结构的2; 4; 6-三取代嘧啶类新型非核苷逆转录酶抑制剂的设计与优化及其改进的抗药性谱》的更正”

2025-10-230
OAAI
Structure- and Privileged Fragment-Based Iterative Optimization: Discovery of 2,4-Disubstituted-6-aminopyrimidines as Novel HIV-1 NNRTIs with Potent Activity against Drug-Resistant Strains and Favorable Safety Profiles

基于结构和特权片段的迭代优化: 发现2,4-二取代-6-氨基嘧啶作为新型HIV-1 nnrti,对耐药菌株具有有效活性和良好的安全性

2025-10-010
PRE
IRG1 catalyzed energy metabolite itaconic acid restrains type I interferon-dependent immune responses by alkylation of TBK1

IRG1催化产生的能量代谢物衣康酸通过烷基化TBK1来抑制I型干扰素依赖的免疫应答。

2025-09-260
PREAI
Design, synthesis, and biological evaluation of dual-site HIV-1 inhibitors simultaneously targeting the NNRTI binding pocket and an adjacent site with favorable resistance profiles

双位点HIV-1抑制剂的分子设计、合成及其生物活性评价:同时靶向NNRTI结合口袋及相邻位点,并表现出有利的耐药性谱。

2025-08-260
PRE
Further exploring the tolerant region II: Identification of 2,4,5-trisubstituted pyrimidines as HIV-1 reverse transcriptase allosteric inhibitors with desirable antiviral activities and reduced cytotoxicity

进一步探索耐受区域II:鉴定2,4,5-三取代嘧啶类作为具有理想抗病毒活性和降低细胞毒性的HIV-1逆转录酶别构抑制剂

2025-07-210
PRE
Probing the Dominant Motifs within the Hydrophobic Channel Yields Oxadiazole-Containing Diarylpyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors

探查疏水通道中的优势基序产生含恶二唑的二芳基嘧啶衍生物,作为强效HIV-1非核苷类逆转录酶抑制剂

2025-07-170
PRE